Is Your Fiber Choice Causing Bloating in GLP-1 Users?

GLP-1 medications slow down digestion, making fiber stay in the gut longer. But not all fibres are equal. The wrong ones start causing bloating, nausea, and discomfort that your consumers can’t tolerate.

General Mills is running clinical trials with GLP-1 users, comparing inulin, fiber blends, and resistant starch to figure out which fibers work without wrecking GI tolerance. Other companies are formulating protein + fiber combinations that consumers actually tolerate.

This report explores the key developments reshaping the Fibre choice in GLP-1 companion foods, offering valuable insights to guide your formulation strategies and keep you ahead of shifting market demands.

What’s Inside the Report?

Discover the fiber science behind GLP-1 companion foods:

✓ Why certain fibers exacerbate GI symptoms in GLP-1 users (and which fermentation profiles offer better tolerance)

✓ The 4 fiber categories for GLP-1 formulations: Highly fermentable (inulin, FOS) vs. slowly fermentable (resistant dextrin, Fibersol) vs. low-fermentable (psyllium) vs. resistant starches, and how each impacts metabolic response and digestive comfort

✓ Clinical evidence: Which fibers trigger GLP-1 secretion at 60 minutes post-ingestion

✓ New ingredients enhancing GLP-1 activity: Glycerol monodecanoate (GMD), bioactive wheat peptides (LPQ/LPQF), and hydrolyzed collagen with dosages, applications, and clinical data

✓ How major players are responding: Product formulations from Nestlé, Danone, Lactalis, Kate Farms, and others, including protein types, fiber sources, and positioning strategies

✓ Patent intelligence: What Food Sciences Corporation, ADM/Matsutani, Hangzhou Kangyuan, and Genki Forest are protecting in GLP-1 food innovation

Sign up now to get the comprehensive report on Fibre in GLP-1 Companion Food!